$25.28
Last update: Dec 12, 8:00 PM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Amplify Weight Loss Drug & Treatment ETF (THNR) Stock Price, Quote, News & History
THNRARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
2.78M
Fund Score
Key Statistics
Open
-
High
-
52 Wk High
$26.27
AUM
2.78M
Dividend
-
Ex-Div Date
-
Volume
-
Market Cap
$198.57B
Mgmt Fee
0.59%
P/E Ratio
8.97
Prev. Close
$25.28
Low
-
52 Wk Low
$18.56
Shares Out
110.00K
Yield
-
Div. Freq
-
Avg. Volume Daily
1.45K
Beta
0.51
Avg. Expense Ratio
0.59%
P/B Ratio
1.47
Recent Amplify Weight Loss Drug & Treatment ETF News
FAQ
Q
How do I buy Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
You can purchase shares of Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) through any online brokerage.
Q
Who are Amplify Weight Loss Drug & Treatment ETF (THNR) competitors?
A
There are no as such competitors for Amplify Weight Loss Drug & Treatment ETF.
Q
What is the forecast, or price target, for Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
There is no analysis for Amplify Weight Loss Drug & Treatment ETF to provide a consensus price target.
Q
What is the current price for Amplify Weight Loss Drug & Treatment ETF (THNR)?
A
The stock price for Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) is $25.2779 last updated December 12, 2025 at 8:00 PM EST.
Q
Does Amplify Weight Loss Drug & Treatment ETF (THNR) pay a dividend?
A
There are no upcoming dividends for Amplify Weight Loss Drug & Treatment ETF.
Q
When is Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) reporting earnings?
A
Amplify Weight Loss Drug & Treatment ETF does not have any upcoming earnings scheduled.
Q
Is Amplify Weight Loss Drug & Treatment ETF (THNR) going to split?
A
There is no upcoming split for Amplify Weight Loss Drug & Treatment ETF.
Key Statistics
Open
-
High
-
52 Wk High
$26.27
AUM
2.78M
Dividend
-
Ex-Div Date
-
Volume
-
Market Cap
$198.57B
Mgmt Fee
0.59%
P/E Ratio
8.97
Prev. Close
$25.28
Low
-
52 Wk Low
$18.56
Shares Out
110.00K
Yield
-
Div. Freq
-
Avg. Volume Daily
1.45K
Beta
0.51
Avg. Expense Ratio
0.59%
P/B Ratio
1.47
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Short Term Safe |
| Investment Style | Large Cap Blend |
| Fund Inception | May 21, 2024 |
| Managers | Dustin Lewellyn Ernesto Tong |
| Definition | Fixed income fund portfolio contains a large percentage of securities with low duration and superior credit quality |
Investment Policy
The Index is comprised of global companies expected to economically benefit from weight loss drug development. The Index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs.
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved